SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-07-003049
Filing Date
2007-05-10
Accepted
2007-05-10 13:26:43
Documents
5
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. 10-Q b65117ape10vq.htm 10-Q 329571
2 EX-31.1 SECTION 302 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER b65117apexv31w1.htm EX-31.1 8708
3 EX-31.2 SECTION 302 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER b65117apexv31w2.htm EX-31.2 8423
4 EX-32.1 SECTION 906 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER b65117apexv32w1.htm EX-32.1 3466
5 EX-32.2 SECTION 906 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER b65117apexv32w2.htm EX-32.2 3520
  Complete submission text file 0000950135-07-003049.txt   355149
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50743 | Film No.: 07836391
SIC: 2834 Pharmaceutical Preparations